Cite
HARVARD Citation
Forster, M. et al. (n.d.). Phase I study of lurbinectedin (PM01183) in combination with cisplatin (CDDP) with or without aprepitant in patients (pts) with advanced solid tumors. European journal of cancer. pp. S134-. [Online].